Navigation Links
Immucor Announces Update to Second Quarter Conference Call Number
Date:1/7/2008

NORCROSS, Ga., Jan. 7 /PRNewswire-FirstCall/ -- Immucor, Inc. (Nasdaq: BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced an update to the telephone conference call number for its second quarter earnings call to be held on Tuesday, January 8, 2008 at 8:30 AM (EST). To participate in the telephone conference call, dial 1-888-950-8044 and passcode BLUD.

For more information on Immucor, please visit our website at http://www.immucor.com.

Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor markets a complete family of automated instrumentation for all of its market segments.


'/>"/>
SOURCE Immucor, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Immucor, Inc. Appoints New Chief Financial Officer
2. Immucor Announces Record Fiscal First Quarter Revenues
3. Immucor Schedules First Quarter Earnings Release and Conference Call
4. New Poll Announces Link Between Friends and Family Influence and a Healthy Lifestyle
5. Kensey Nash Corporation Announces Its Second Quarter 2008 Earnings Release Date and Teleconference
6. QED International Associates Announces Changes to the HealthShares(TM) Emerging Cancer Index
7. BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call
8. amfAR announces inaugural Mathilde Krim Fellowship Awards for AIDS research
9. Torchmark Corporation Announces Change in Domicile State of Insurance Subsidiaries to Nebraska
10. Roxane Laboratories, Inc. Announces the Launch of Granisetron Hydrochloride Tablets, 1mg
11. Roxane Laboratories, Inc. Announces the Launch of Balsalazide Disodium Capsules, 750mg
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... 29, 2016 , ... World Patent Marketing , a ... invention which aids in proper muscle development. , "The Gym & Exercise Equipment ... of World Patent Marketing. "Globalization has threatened the future growth of the industry ...
(Date:4/29/2016)... ... April 29, 2016 , ... The Gluten-Free Certification Program (GFCP), ... announce the launch of the GFCP Scoop in response to consumer ... of the GFCP Scoop site is to keep the gluten-free community ...
(Date:4/29/2016)... CA (PRWEB) , ... April 29, 2016 , ... Melanoma is the deadliest type of ... to blame for the majority of skin cancer deaths. More than 10,000 people are expected ... age at diagnosis is 62, it is the one of the most commonly diagnosed cancers ...
(Date:4/29/2016)... ... ... Dr. Robert Mondavi, one of the dentists in Torrance , is ... field as more patients are discovering the many different ways they can change and ... available to them and which ones might work for their smiles. , “One ...
(Date:4/29/2016)... ... , ... New York City based oral and maxillofacial surgeon Dr. Majid Jamali is ... treat obstructive sleep apnea. Dr. Jamali is proud to offer this permanent solution to patients ... or both jaw bones. This surgery is performed to correct the alignment of the jaw. ...
Breaking Medicine News(10 mins):
(Date:4/29/2016)... 29, 2016 Acquisition Expands ... Product Development Capabilities in North America ... . Indegene ( http://www.indegene.com ), ... acquisition of Skura Corporation,s life science business. Skura,s ... sales enablement technology for life science organizations and ...
(Date:4/29/2016)... 29, 2016 ... Sanofi, leader mondial et ... résultats pour le premier trimestre 2016. ... Contamine, commente les résultats du premier ... pour le reste de l,année. ...
(Date:4/29/2016)... Glycotope GmbH, a clinical-stage immuno-oncology company built ... Dr. Alfredo Zurlo as Chief Medical Officer. ... years clinical experience and a proven track record in ... at Mologen AG where he was Chief Medical Officer ... held various positions at F Hoffmann La Roche and ...
Breaking Medicine Technology: